The US Food and Drug Administration (FDA) approved the first-ever anti-depression nasal spray, Spravato. The pharmaceutical ...

The recent acquisitions by pharmaceutical giants Johnson & Johnson and Bristol Myers Squibb, worth a combined $28billion, ...

GH Research's inhaled psychedelic therapy GH001 has shown promise in a mid-stage trial in treatment-resistant depression (TRD ...

The small, Ireland-based company GH Research said its inhaled version of mebufotenin — a molecular cousin to psilocybin — was ...

Ketamine has long been seen as a potential ... now on the label of AstraZeneca and Daiichi Sankyo's Enhertu. Johnson & Johnson's Spravato has become the first standalone drug to be cleared by ...

Medicaid in Wisconsin has expanded to cover ketamine infusions as of Jan. 1, sparking conversations about the nuances in type ...

Jamie Boland (pictured), founded and owned Ancoats Coffee Co, an independent Manchester roastery and speciality coffee shop.

Duato discusses the split of the business, dealing with the scrutiny brought about by lawsuits, and 2025 priorities.

After her tour for 2023’s Safe To Run, Esther Rose considered quitting music. Instead, the folk musician quit drinking and focused on therapy. Now, she’s back with the new album Want, arriving in May.

Trump has given Ketamine-addled Elon Musk and six boys, ages 19-24, control over the US Treasury Department’s data and ...

Some might describe Johnson & Johnson's business as boring, but sometimes, that's not such a bad thing. Selling pharmaceutical products is a steady and reliable business even when the economy is ...

Johnson & Johnson (NYSE: JNJ) didn't have an exceptional 2024; in fact, it was one of the worst-performing stocks on the vaunted, 30-company Dow Jones Industrial Average that year. Yet, if the ...